Protalix BioTherapeutics
Plant-based Proteins with Improved Therapeutic Profiles
Active
Public
Startup
Karmiel
Founded 1994-01
Protalix BioTherapeutics is a biopharmaceutical company focused on the development, production, and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant-cell-based protein expression system. The company's pipeline consists of proprietary, potentially clinically superior versions of recombinant therapeutic protein…
SectorHealth Tech & Life Sciences
StagePublic
Total raised$159.9M
Employees194
Founded1994-01
HQKarmiel
Crunchbaseprotalix-biotherapeutics
Patents1
Confidence91
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals